Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost-benefit analysis of a plateletapheresis program.

J G McFarland, E B Larson, R S Hillman

    Transfusion
    |January 1, 1986
    PubMed
    Summary

    A community donor platelet apheresis program (CDPP) provides HLA-matched platelets, proving cost-effective. This program reduced random-donor platelet use and achieved significant cost savings in its first year.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies.

    Molecular psychiatry·2017
    Same author

    Letters to the editors.

    Journal of general internal medicine·2016
    Same author

    Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.

    Vox sanguinis·2016
    Same author

    The association of statin therapy with the risk of recurrent venous thrombosis.

    Journal of thrombosis and haemostasis : JTH·2016
    Same author

    Further studies to evaluate methods of leucoreduction to prevent alloimmune platelet refractoriness and induce tolerance in a dog platelet transfusion model.

    Vox sanguinis·2016
    Same author

    Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.

    Clinical pharmacology and therapeutics·2016

    Area of Science:

    • Hematology
    • Transfusion Medicine
    • Health Economics

    Background:

    • Patients refractory to random-donor platelets (RDPs) require specialized transfusion support.
    • HLA-matched platelet transfusions are crucial for refractory patients.
    • Community-based apheresis programs offer a potential solution.

    Purpose of the Study:

    • To determine the costs and benefits of a community donor platelet apheresis program (CDPP).
    • To evaluate the cost-effectiveness of CDPP in providing HLA-matched platelet transfusions.
    • To assess the impact of CDPP on platelet and red cell utilization.

    Main Methods:

    • Cost-benefit analysis of establishing and maintaining a CDPP.
    • Comparison of RDP usage before and after CDPP implementation.
    • Matched cohort study of marrow transplant patients receiving CDPP transfusions.
    • Analysis of platelet and red cell use in acute leukemia patients supported by CDPP.

    Main Results:

    • First-year costs for CDPP were $127,520 (1982).
    • Estimated first-year net cost savings ranged from $177,570 to $272,253 (1982 dollars).
    • Cost-to-benefit ratios were 1:1.39 to 1:2.14.
    • CDPP transfusions were as effective as family donors in marrow transplant patients.
    • Significant reductions in platelet and red cell use were observed in acute leukemia patients.

    Conclusions:

    • The community donor platelet apheresis program (CDPP) is a cost-effective strategy.
    • CDPP improves platelet support for refractory patients.
    • The program demonstrates economic benefits and efficient resource utilization.

    Related Experiment Videos